Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Field Trip Health Ltd
(NQ:
FTRP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 16, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Field Trip Health Ltd
< Previous
1
2
3
4
5
6
7
Next >
3 Psychedelic Stocks for Potential Out-of-This-World Gains
November 18, 2021
Psychedelic drugs could be a major game-changer when it comes to treating mental illness. All as psilocybin, LSD, and MDMA show progress.
Via
InvestorPlace
Compass Pathways Phase II Results: A Disappointment For Some, An Opportunity For Others
November 11, 2021
Compass Pathways reported
Via
Talk Markets
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
October 26, 2021
The Week In Psychedelics
Via
Benzinga
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?
October 23, 2021
The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last.
Via
Talk Markets
Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma
October 19, 2021
Ronan Levy, co-founder and executive chairman of Field Trip Ltd (NASDAQ: FTRP), a company developing a network of psychedelics-assisted therapy clinics; Doug Drysdale, CEO,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Field Trip Stock Could Climb 300% In One Year
September 02, 2021
On Wednesday, HC WainWright began coverage of Field Trip Health (NASDAQ:
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
This Company Just Extended its Reach into the United Kingdom by Opening its First Ketamine Therapy Clinic
October 18, 2021
Photo by cottonbro from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...
Via
Benzinga
Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021
October 15, 2021
Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month.
Via
Talk Markets
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
This Psychedelic Therapies Stock Has A Better One-Year Return Than Nio, AMD, Nvidia And GE
October 13, 2021
Field Trip Health Ltd (NASDAQ: FTRP) is a global leader in psychedelic therapies, and over the past year, bringing eye-popping gains to investors’ portfolios. Since October...
Via
Benzinga
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
October 04, 2021
The Week In Psychedelics:
Via
Benzinga
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
October 01, 2021
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
October 01, 2021
This article by Jason Najum was originally published on
Via
Benzinga
Elon Musk Acknowledges Therapeutic Potential Of Psychedelic Drugs: Will This Impact The Markets?
September 29, 2021
Elon Musk expressed his support for the therapeutic potential of psychedelic drugs. The Space X and
Via
Benzinga
The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio?
September 21, 2021
We compare and contrast the three psychedelic drug ETFs and assess which investor needs each addresses.
Via
Talk Markets
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
September 20, 2021
Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
September 13, 2021
Last Week In Psychedelics:
Via
Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...
Via
Benzinga
Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A
September 07, 2021
Contents
Via
Benzinga
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
54 Biggest Movers From Yesterday
September 02, 2021
Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands...
Via
Benzinga
Why Field Trip Health Shares Are Trading Higher Today
September 01, 2021
Field Trip Health (NSADAQ: FTRP) shares are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and a $20 price target. The firm said it...
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
September 01, 2021
Gainers Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands Group, Inc. (NASDAQ:...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
September 01, 2021
Upgrades For Chatham Lodging Trust (NYSE:
Via
Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
September 01, 2021
Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-...
Via
Benzinga
75 Biggest Movers From Yesterday
August 04, 2021
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a...
Via
Benzinga
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
August 02, 2021
Last week in Psychedelics:
Via
Benzinga
Field Trip Health Debuts On Nasdaq With Average Performance, Looks To Expand Footprint Of Psychedelics Clinics
July 29, 2021
Field Trip Health (TSX:FTRP) (NASDAQ:
Via
Benzinga
Another Psychedelic Stock Debuts, As This One Sets Up In A Base
July 29, 2021
Field Trip Health dipped in its first day on the Nasdaq, making it the latest psychedelics company to hit a big U.S. exchange.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.